FDA Inspection 1196422 — Marsh Regional Blood Center

Marsh Regional Blood Center — FEI 1074776

The FDA completed an inspection of Marsh Regional Blood Center on December 15, 2022 in Bristol, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 15, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Bristol, TN (United States)